Maximilian A R Strobl

Cited by

	All	Since 2019
Citations	427	419
h-index	11	11
i10-index	13	13

160

120

2016201720182019202020212022202320242 2 4 4 24 45 48 136 160

Public access

View all

15 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Alexander R. A. AndersonChair of Integrated Mathematical Oncology, Moffitt Cancer CenterVerified email at moffitt.org
Mark Robertson-TessiIntegrated Mathematical Oncology, Moffitt Cancer CenterVerified email at moffitt.org
Jeffrey WestIntegrated Mathematical Oncology, Moffitt Cancer CenterVerified email at moffitt.org
Philip MainiProfessor of Mathematical BiologyVerified email at maths.ox.ac.uk
Mehdi DamaghiAssistant professor at Stony Brook medicine, dept of pathology and SB cancer centerVerified email at stonybrookmedicine.edu
Joel S BrownMoffitt Cancer CenterVerified email at darwiniandynamics.org
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterVerified email at moffitt.org
Andriy MarusykMoffitt Cancer CenterVerified email at moffitt.org
Andrew KrauseDurham UniversityVerified email at durham.ac.uk
Liliana Ramona DemenescuDepartment of Psychiatry, Psychotherapy and Psychosomatic, Uniklinik Aachen, GermanyVerified email at canlab.de
Maarten De VosESAT - Stadius & Department of Development and Regeneration, KU Leuven, BelgiumVerified email at kuleuven.be
Michael LindemannBaden-Wuerttemberg Cooperative State UniversityVerified email at dhbw-loerrach.de
Heiko EnderlingProfessor, Radiation Oncology, Inst. for Data Science, MD Anderson Cancer Center, Houston, TX, USAVerified email at mdanderson.org
Lee Curtin, PhDSenior Bioinformatician, Precision Neurotherapeutics Innovation Program, Mayo ClinicVerified email at mayo.edu
Daniel NicholEvolutionary Genomics and Modelling, Institute of Cancer Research, UKVerified email at icr.ac.uk
Ilke TunaliEli Lilly & CompanyVerified email at lilly.com
Jamie DeanJunior Group Leader, University College LondonVerified email at ucl.ac.uk
Iman Tavassoly, MD, PhDVirginia Tech, Icahn School of Medicine at Mount SinaiVerified email at vt.edu
Inmaculada C. SorribesQuantitative Pharmacology and Pharmacometrics Immune/Oncology, MerckVerified email at merck.com
Jakob Nikolas Kather, MD, MScElse Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, GermanyVerified email at tu-dresden.de

Maximilian A R Strobl

Postdoctoral Research Fellow, Cleveland Clinic, USA

Verified email at ccf.org - Homepage

Mathematical Oncology Evolutionary Therapy Cancer Ecology and Evolution


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Turnover modulates the need for a cost of resistance in adaptive therapy MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, JS Brown, ... Cancer research 81 (4), 1135-1147, 2021	111	2021
Spatial structure impacts adaptive therapy by shaping intra-tumoral competition MAR Strobl, J Gallaher, J West, M Robertson-Tessi, PK Maini, ... Communications Medicine 2 (1), 1-18, 2022	60	2022
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation J West, F Adler, J Gallaher, M Strobl, R Brady-Nicholls, J Brown, ... Elife 12, e84263, 2023	39	2023
Look me in the eye: evaluating the accuracy of smartphone-based eye tracking for potential application in autism spectrum disorder research MAR Strobl, F Lipsmeier, LR Demenescu, C Gossens, M Lindemann, ... Biomedical engineering online 18 (1), 1-12, 2019	37	2019
Immunosuppressive niche engineering at the onset of human colorectal cancer CD Gatenbee, AM Baker, RO Schenck, M Strobl, J West, MP Neves, ... Nature Communications 13 (1), 1-16, 2022	33	2022
Mix and Match: Phenotypic Coexistence as a Key Facilitator of Cancer Invasion MAR Strobl, AL Krause, M Damaghi, R Gillies, ARA Anderson, PK Maini Bulletin of Mathematical Biology 82 (1), 1-26, 2020	24	2020
On simulated annealing phase transitions in phylogeny reconstruction MAR Strobl, D Barker Molecular phylogenetics and evolution 101, 46-55, 2016	22	2016
Treatment of evolving cancers will require dynamic decision support MAR Strobl, J Gallaher, M Robertson-Tessi, J West, ARA Anderson Annals of Oncology 34 (10), 867-884, 2023	19	2023
Drug dependence in cancer is exploitable by optimally constructed treatment holidays J Maltas, ST Killarney, KR Singleton, MAR Strobl, R Washart, KC Wood, ... Nature Ecology & Evolution 8 (1), 147-162, 2024	13	2024
Combining radiomics and mathematical modeling to elucidate mechanisms of resistance to immune checkpoint blockade in non-small cell lung cancer D Saeed-Vafa, R Bravo, JA Dean, A El-Kenawi, N Mon Père, M Strobl, ... BioRxiv, 190561, 2017	13	2017
Feasibility of an Evolutionary Tumor Board for Generating Novel Personalized Therapeutic Strategies M Robertson-Tessi, JS Brown, M Poole, M Johnson, A Marusyk, ... medRxiv, 2023.01. 18.23284628, 2023	12	2023
Inter-and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics J Gallaher, M Strobl, J West, R Gatenby, J Zhang, M Robertson-Tessi, ... Cancer Research, CAN-22-2558, 2023	11*	2023
Antifragile therapy J West, B Desai, M Strobl, L Pierik, R Vander Velde, C Armagost, R Miles, ... bioRxiv, 2020.10. 08.331678, 2021	11	2021
Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy K Gallagher, MAR Strobl, DS Park, FC Spoendlin, RA Gatenby, PK Maini, ... Cancer Research 84 (11), 1929-1941, 2024	8	2024
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling M Strobl, A Martin, J West, J Gallaher, M Robertson-Tessi, R Gatenby, ... bioRxiv, 2023.03. 22.533721, 2023	7	2023
Harnessing patient-specific response dynamics to optimize evolutionary therapies for metastatic clear cell renal cell carcinoma-Learning to adapt IC Sorribes, A Basu, R Brady, PM Enriquez-Navas, X Feng, JN Kather, ... bioRxiv, 563130, 2019	3	2019
To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy MAR Strobl, AL Martin, J West, J Gallaher, M Robertson-Tessi, R Gatenby, ... Cell Systems 15 (6), 510-525. e6, 2024	1	2024
The balance between intrinsic and ecological fitness defines new regimes in eco-evolutionary population dynamics RJ Barker-Clarke, JM Gray, MAR Strobl, J Maltas, DS Tadele, ... bioRxiv, 2023.03. 15.532871, 2023	1*	2023
Learning to Adapt-Deep Reinforcement Learning in Treatment-Resistant Prostate Cancer K Gallagher, M Strobl, R Gatenby, P Maini, A Anderson bioRxiv, 2023.04. 28.538766, 2023	1	2023
Connecting the Microenvironmental Niche to Treatment Response in Ovarian Cancer M Strobl, M Wicker, V Adhikarla, WA Shockey, E Lakatos, P Pooladvand, ... BioRxiv, 452052, 2018	1	2018

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors